Hongbo Du

598 total citations
27 papers, 342 citations indexed

About

Hongbo Du is a scholar working on Epidemiology, Hepatology and Cancer Research. According to data from OpenAlex, Hongbo Du has authored 27 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Hepatology and 7 papers in Cancer Research. Recurrent topics in Hongbo Du's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Hongbo Du is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Hongbo Du collaborates with scholars based in China, Australia and Canada. Hongbo Du's co-authors include Yongan Ye, Danan Gan, Xiaoke Li, Jiaxin Zhang, Jiaying Zhang, Xu Cao, Mei Han, Guang Chen, Peng Zhang and Ludan Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Medicine.

In The Last Decade

Hongbo Du

23 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongbo Du China 9 123 88 87 84 60 27 342
Soo Teik Lee South Korea 11 152 1.2× 62 0.7× 103 1.2× 50 0.6× 48 0.8× 21 351
Takahiro Dohmen Japan 9 100 0.8× 155 1.8× 42 0.5× 88 1.0× 37 0.6× 19 335
Haizhou Lou China 10 121 1.0× 88 1.0× 59 0.7× 119 1.4× 107 1.8× 21 379
Enxin Wang China 9 148 1.2× 95 1.1× 56 0.6× 130 1.5× 36 0.6× 20 365
Jana Y. Wo Hong Kong 7 246 2.0× 60 0.7× 101 1.2× 60 0.7× 48 0.8× 8 401
Bangxiang Xie China 10 191 1.6× 82 0.9× 93 1.1× 30 0.4× 48 0.8× 22 378
Maya Sultan Israel 8 137 1.1× 78 0.9× 39 0.4× 67 0.8× 25 0.4× 10 337
Chang-Min Kim South Korea 10 103 0.8× 68 0.8× 37 0.4× 117 1.4× 45 0.8× 14 308
Na He China 11 109 0.9× 100 1.1× 52 0.6× 39 0.5× 45 0.8× 41 350

Countries citing papers authored by Hongbo Du

Since Specialization
Citations

This map shows the geographic impact of Hongbo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Du more than expected).

Fields of papers citing papers by Hongbo Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Du. The network helps show where Hongbo Du may publish in the future.

Co-authorship network of co-authors of Hongbo Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbo Du. A scholar is included among the top collaborators of Hongbo Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbo Du. Hongbo Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Qiuyue, Wenying Qi, Xiaoke Li, et al.. (2025). Chinese Medicine for Non-Alcoholic Fatty Liver Disease: Targeting Key Signaling Pathways. The American Journal of Chinese Medicine. 53(5). 1379–1410.
3.
Wang, Qiuyue, Wenying Qi, Xiaoke Li, et al.. (2025). Chinese Medicine for the Treatment of Liver Cirrhosis: The Mechanism of Cellular Autophagy. The American Journal of Chinese Medicine. 53(2). 409–433.
4.
Wu, Jianping, et al.. (2025). Nonlinear responses of coupled socioecological systems to land use and climate changes in the Yangtze river basin. Scientific Reports. 15(1). 6940–6940. 2 indexed citations
5.
Zheng, Shihao, et al.. (2025). Pan-cancer analysis of UDP-glucose 6-dehydrogenase in human tumors and its function in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 17(7). 105981–105981.
6.
Xue, Chengyuan, Xiaoke Li, Qiyao Liu, et al.. (2024). Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Frontiers in Pharmacology. 15. 1381476–1381476. 2 indexed citations
7.
Zhang, Jing, et al.. (2024). The Effect of Urbanization and Farmland to Forests Program on Surface Runoff. Water Resources Management. 39(5). 2299–2316. 4 indexed citations
8.
Liu, Bingyan, et al.. (2024). Image-based molecular representation learning for drug development: a survey. Briefings in Bioinformatics. 25(4). 5 indexed citations
9.
Li, Shuo, Zhiguo Li, Hongbo Du, et al.. (2023). Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model. Frontiers in Public Health. 11. 1137738–1137738. 2 indexed citations
10.
11.
Liu, Ruijia, Xu Cao, Yijun Liang, et al.. (2022). Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma. Journal of Inflammation Research. Volume 15. 5801–5814. 10 indexed citations
12.
Zhang, Jiaxin, Jiaying Zhang, Ziwei Guo, et al.. (2022). Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome?. International Immunopharmacology. 115. 109627–109627. 2 indexed citations
13.
Li, Xiaoke, Yufeng Xing, Huanming Xiao, et al.. (2021). A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels. Frontiers in Medicine. 8. 688091–688091. 9 indexed citations
14.
Li, Zhiguo, Ying Li, Xiaoke Li, et al.. (2020). Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis. The Turkish Journal of Gastroenterology. 33(2). 136–144. 8 indexed citations
15.
Zhang, Jiaxin, Guang Chen, Peng Zhang, et al.. (2020). The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLoS ONE. 15(2). e0228857–e0228857. 150 indexed citations
16.
Zhang, Jiaxin, Guang Chen, Zhiguo Li, et al.. (2020). Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis. Journal of Cancer. 11(20). 5953–5970. 33 indexed citations
17.
Li, Zhiguo, Ying Li, Xiaoke Li, et al.. (2018). Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis. Medicine. 97(34). e11950–e11950. 4 indexed citations
18.
Gan, Danan, Ying Li, Peng Zhang, et al.. (2018). JianPi HuaZhuo XingNao formula (Chinese herbal medicine) for the treatment of minimal hepatic encephalopathy. Medicine. 97(17). e0526–e0526. 1 indexed citations
19.
Gan, Danan, et al.. (2017). Chinese Classical Formula Sijunzi Decoction and Chronic Atrophic Gastritis: Evidence for Treatment Approach?. Evidence-based Complementary and Alternative Medicine. 2017(1). 9012929–9012929. 20 indexed citations
20.
Du, Hongbo, et al.. (2017). Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network. Neoplasma. 64(6). 816–823. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soo Teik Lee Breakdown of academic impact, for papers by Takahiro Dohmen Breakdown of academic impact, for papers by Haizhou Lou Breakdown of academic impact, for papers by Enxin Wang Breakdown of academic impact, for papers by Jana Y. Wo Breakdown of academic impact, for papers by Bangxiang Xie Breakdown of academic impact, for papers by Maya Sultan Breakdown of academic impact, for papers by Chang-Min Kim Breakdown of academic impact, for papers by Na He
Rankless by CCL
2026